V-Wave
William Abraham serves as a Professor of Medicine, Physiology, and Cell Biology at The Ohio State University Wexner Medical Center since October 2002. In this role, William holds several titles including College of Medicine Distinguished Professor, Associate Dean for Clinical Research, Medical Director of the Clinical Trials Management Office, Chair of Excellence in Cardiovascular Medicine, and Director of the Division of Cardiovascular Medicine. Since January 2019, William has also been the Chief Medical Officer at V-Wave. William obtained an MD in Medicine from Harvard Medical School between 1982 and 1986 and earned a BA in Honors Philosophy from the University of Pittsburgh from 1978 to 1982.
This person is not in any offices
V-Wave
V-Wave Ltd. is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with Chronic Heart Failure (HF). V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment. V-Wave hasdeveloped a proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the overall quality of life.The original concept and development started in Israel with a talented team of engineers and medical scientists. The company’s senior management has decades of experience successfully developing, clinically testing and bringing to market multiple implantable cardiovascular devices.